[Therapeutic prospects of angiogenesis inhibitors in cancerology]

Rev Mal Respir. 1999 Nov;16(5):854-5.
[Article in French]
No abstract available

MeSH terms

  • Angiogenesis Inhibitors / therapeutic use*
  • Angiostatins
  • Animals
  • Antineoplastic Agents / therapeutic use*
  • Carcinoma, Small Cell / drug therapy
  • Collagen / therapeutic use
  • Endostatins
  • Humans
  • Hydroxamic Acids / therapeutic use
  • Lung Neoplasms / drug therapy
  • Matrix Metalloproteinase Inhibitors*
  • Mice
  • Neoplasms / drug therapy*
  • Neoplasms, Experimental / drug therapy
  • Neovascularization, Pathologic / drug therapy*
  • Peptide Fragments / therapeutic use
  • Plasminogen / therapeutic use
  • Protease Inhibitors / therapeutic use*
  • Randomized Controlled Trials as Topic

Substances

  • Angiogenesis Inhibitors
  • Antineoplastic Agents
  • Endostatins
  • Hydroxamic Acids
  • Matrix Metalloproteinase Inhibitors
  • Peptide Fragments
  • Protease Inhibitors
  • Angiostatins
  • Plasminogen
  • Collagen
  • marimastat